Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report

Name: Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report
SKU: 7381
Price: 30.00 USD
Availability: InStock

$30.00

Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report

By Neel Patel, Katherine B. Landry, Rachel E. Fargason, Badari Birur

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 47 No. 1 Articles - 2017 Tags: badari-birur, bipolar-disorder, hyperammonemia, katherine-b-landry, neel-patel, rachel-e-fargason, reversible-encephalopathy, valproic-acid

Description

Description

Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report

By Neel Patel, Katherine B. Landry, Rachel E. Fargason, Badari Birur

40-44_PB-47-1-2017-Patel

Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report

Description

Innovative Treatment Strategies With Anticonvulsants: A Focus on Bipolar Disorder

What Mood Symptoms may be most Difficult to Rate?

New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing

Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report

Description

Related products

Innovative Treatment Strategies With Anticonvulsants: A Focus on Bipolar Disorder

What Mood Symptoms may be most Difficult to Rate?

New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing